Labcorp Holdings Inc. logo

Labcorp Holdings Inc. (N6B)

Market Open
5 Dec, 07:05
XFRA XFRA
222. 00
-4
-1.77%
- Market Cap
- P/E Ratio
2.88% Div Yield
0 Volume
- Eps
226
Previous Close
Day Range
222 222
Year Range
183 248
Want to track N6B and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 62 days

Summary

N6B trading today lower at €222, a decrease of 1.77% from yesterday's close, completing a monthly decrease of -2.63% or €6. Over the past 12 months, N6B stock gained 1.37%.
N6B pays dividends to its shareholders, with the most recent payment made on Sep 11, 2025. The next announced payment will be in In 6 days on Dec 11, 2025 for a total of €0.72.
The last earnings report, released on Oct 23, 2025, exceeded the consensus estimates by 0.07%. On average, the company has surpassed earnings expectations by 0.08%, based on the last three reports. The next scheduled earnings report is due on Feb 05, 2026.
Labcorp Holdings Inc. has completed 5 stock splits, with the recent split occurring on May 20, 2024.
The company's stock is traded on 8 different exchanges and in various currencies, with the primary listing on NYSE (USD).

N6B Chart

Should You Continue to Hold LH Stock in Your Portfolio?

Should You Continue to Hold LH Stock in Your Portfolio?

Labcorp expands in specialty testing and ramps up acquisitions, but macro pressures and currency headwinds complicate its growth outlook.

Zacks | 3 days ago
Labcorp (LH) Up 8.1% Since Last Earnings Report: Can It Continue?

Labcorp (LH) Up 8.1% Since Last Earnings Report: Can It Continue?

Labcorp (LH) reported earnings 30 days ago. What's next for the stock?

Zacks | 1 week ago
Why Labcorp Holdings (LH) is a Top Value Stock for the Long-Term

Why Labcorp Holdings (LH) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 1 week ago

Labcorp Holdings Inc. (N6B) FAQ

What is the stock price today?

The current price is €222.00.

On which exchange is it traded?

Labcorp Holdings Inc. is listed on NYSE.

What is its stock symbol?

The ticker symbol is N6B.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 2.88%.

What is its market cap?

As of today, no market cap data is available.

What is the earnings per share?

The EPS is 3.94.

When is the next earnings date?

The next earnings report will release on Feb 05, 2026.

Has Labcorp Holdings Inc. ever had a stock split?

Labcorp Holdings Inc. had 5 splits and the recent split was on May 20, 2024.

Labcorp Holdings Inc. Profile

- Industry
- Sector
Adam H. Schechter CEO
XFRA Exchange
US5049221055 ISIN
US Country
60,900 Employees
26 Nov 2025 Last Dividend
3 Jul 2023 Last Split
29 Mar 1990 IPO Date

Overview

Laboratory Corporation of America Holdings, widely known as Labcorp, is a pioneering life sciences company that plays a crucial role in the healthcare industry by providing essential information aiding in clear and confident decision-making for doctors, hospitals, pharmaceutical companies, researchers, and patients. With a deep commitment to improving health and improving lives, Labcorp operates through two primary segments: Labcorp Diagnostics, which focuses on a wide array of testing services, and Labcorp Drug Development, dedicated to supporting the pharmaceutical and biotech industries in bringing new drugs and therapies to market. The company's history dates back to 1994, and it has since established its headquarters in Burlington, North Carolina, positioning itself as a leader in medical diagnostics and drug development services. Through its extensive range of services and a global network, Labcorp facilitates better health outcomes for millions of people worldwide.

Products and Services

Labcorp distinguishes itself by offering an extensive portfolio of services that cater to various stakeholders in the healthcare and biomedical sectors. Below are some of the key products and services provided by the company:

  • Diagnostic Tests - Labcorp conducts a wide range of routine and specialized diagnostic tests, including but not limited to, blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, vitamin D levels, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, and alcohol and substance-abuse tests. These tests are crucial for early detection, monitoring, and treatment of diseases.
  • Specialty Testing Services - The company provides gene-based and esoteric testing services targeting specific diseases and conditions. This includes anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, and parentage and donor testing, offering advanced diagnostic solutions for complex health questions.
  • Occupational Testing Services - Labcorp extends its services to employers and managed care organizations (MCOs), delivering occupational testing services, medical drug monitoring, chronic disease programs, and kidney stone prevention tests. These services are designed to enhance workplace safety, compliance with regulations, and overall employee health.
  • Health and Wellness Services - The company offers health and wellness services, including health fairs, on-site and at-home testing, vaccinations, and health screenings. These services aim to promote preventative care and healthier lifestyles among employees and communities.
  • Online and Mobile Applications - To facilitate easier access to test results and services, Labcorp offers online and mobile applications that enable patients to view their test results conveniently. It also provides online applications for MCOs and accountable care organizations to manage and streamline healthcare services effectively.
  • Drug Development - Labcorp Drug Development unit offers comprehensive end-to-end drug development, medical device, and companion diagnostic development solutions. From early-stage research to clinical development and commercial market access, Labcorp supports a range of requirements for pharmaceutical, biotechnology, medical device, and diagnostics companies.

Contact Information

Address: 358 South Main Street
Phone: 336 229 1127